Plastic Surgeons Around the World Embrace Non-Surgical Energy-Based Technologies from INMODE LTD

Trending News ☀️

INMODE LTD ($NASDAQ:INMD) is a publicly traded company engaged in the development and commercialization of energy-based medical technologies. Their technologies are designed to improve patient outcomes through minimally invasive procedures. Over the past few years, INMODE LTD has seen an increase in the use of their energy-based technologies in non-surgical cosmetic procedures. Plastic surgeons around the world are now starting to embrace these non-surgical energy-based technologies from INMODE LTD. The most popular applications are fat reduction, hair removal and skin tightening. These treatments are much less invasive than traditional surgical procedures and have also been proven to be highly effective.

Additionally, they offer patients a more cost-effective solution that can be completed in a shorter period of time. The use of these non-surgical energy-based technologies has enabled patients to achieve results that rival those of more invasive procedures. In addition to the improved efficacy, the use of these technologies has resulted in reduced downtime and fewer side effects. This has resulted in an increase in patient satisfaction with the results of their treatments. INMODE LTD is continuing to develop new energy-based technologies that can be used for non-surgical cosmetic procedures. Their commitment to providing safe and effective treatments has made them a leader in the field of energy-based medical technologies.

Price History

On Monday, the stock of INMODE LTD opened at $35.5 and closed at $36.8, representing a 4.4% increase from its last closing price of $35.2. INMODE LTD has been dedicated to the research, development and distribution of innovative medical and aesthetic technologies since its founding. Its products allow physicians to offer a wide range of procedures, from body contouring to skin tightening, with minimal or no downtime. The company has made significant progress in the development of these technologies and has become a leader in the medical aesthetics industry. The company’s products are gaining popularity among plastic surgeons, who are increasingly turning to non-surgical treatments as an alternative to traditional surgical treatments.

These non-surgical treatments are much less invasive and can often provide results that are just as effective as surgical procedures. Furthermore, they do not require the patient to take time off work or have lengthy recovery periods, which makes them a more attractive option for many patients. Overall, INMODE LTD’s stock surge on Monday is reflective of its success in providing advanced non-surgical energy-based technologies that are becoming increasingly popular among plastic surgeons around the world. As the company continues to make progress in its research and development, it is likely that its products and services will become even more widely used. Live Quote…

About the Company

VI Analysis

When considering an investment opportunity, it is important to analyze the company’s fundamentals and long-term potential. VI App simplifies this process, making it easier to assess the risk of an investment. VI Risk Rating has evaluated INMODE LTD as a medium risk investment in terms of both financial and business aspects. This means that there is potential for return, but some risks should be taken into account before investing. VI App has also detected one risk warning in the company’s financial journal. To access this information, interested investors should register on vi.app to gain further insight into the company. It is always important to do your own research when considering an investment opportunity. By utilizing VI App’s tools, investors can quickly analyze the fundamentals of a company and make an informed decision on whether or not to invest. More…

VI Peers

The market for aesthetic medical device is highly competitive with InMode Ltd. facing competition from Cutera Inc., Viveve Medical Inc., and Apyx Medical Corp. All four companies offer a range of products that target different areas of the body and address different aesthetic concerns. InMode Ltd. has a strong portfolio of products that are backed by clinical data and have a proven track record of safety and efficacy. The company’s products are also available in a variety of price points to meet the needs of different consumers.

– Cutera Inc ($NASDAQ:CUTR)

Cutera Inc is a medical device company that provides aesthetic treatments to patients worldwide. Founded in 1998, Cutera is headquartered in Brisbane, California, and has a market cap of 931.59M as of 2022. The company’s Return on Equity is -111.73%. Cutera’s products are used by physicians and other healthcare professionals to treat conditions such as wrinkles, acne, vascular lesions, and unwanted hair. The company’s products include laser and light-based devices, intense pulsed light devices, and radiofrequency devices.

– Viveve Medical Inc ($NASDAQ:VIVE)

Viveve Medical Inc. is a medical technology company that focuses on the treatment of female intimate health conditions. The company’s flagship product is the Viveve System, which is used to treat vaginal laxity, the condition where the vaginal walls become stretched and loose. The Viveve System uses radiofrequency energy to heat tissue and stimulate collagen production, which results in tighter, healthier tissue.

Viveve Medical Inc has a market cap of 6.19M as of 2022. The company’s Return on Equity is -179.17%. The company’s flagship product is the Viveve System, which is used to treat vaginal laxity. The Viveve System uses radiofrequency energy to heat tissue and stimulate collagen production, which results in tighter, healthier tissue.

– Apyx Medical Corp ($NASDAQ:APYX)

Apyx Medical Corp is a medical device company that develops, manufactures, and markets radiofrequency (RF) products for the global surgical market. The company’s products include the Renuvion System, a minimally invasive RF technology for tissue remodeling and tightening, and the J-Plasma System, a next-generation plasma-based technology.

Apyx Medical Corp has a market cap of 149.01M as of 2022, a Return on Equity of -22.62%. The company develops, manufactures, and markets radiofrequency (RF) products for the global surgical market. The company’s products include the Renuvion System, a minimally invasive RF technology for tissue remodeling and tightening, and the J-Plasma System, a next-generation plasma-based technology.

Summary

Investing in INMODE LTD can be a great way to capitalize on the growing trend of non-surgical energy-based technologies. As plastic surgeons around the world increasingly embrace these technologies, INMODE LTD stands to benefit from an influx of business. Their stock price has reflected this, moving up the same day the news was announced. INMODE LTD has a history of being a reliable investment. Over the past year, the company has seen a significant increase in revenue and profitability, which has led to an increase in their share price. This trend is likely to continue as more plastic surgeons adopt their innovative technologies. In addition to its growth potential, INMODE LTD also offers a strong financial position. The company has a healthy balance sheet and solid cash flow, which makes it an attractive option for investors looking for long-term stability.

Its strong financial position also allows it to invest in new technologies and expand its product offerings, which could further drive growth. INMODE LTD is also well-positioned to capitalize on growing demand for non-invasive treatments. The company has a broad range of products, from lasers to radiofrequency devices, which allows them to serve a wide variety of medical needs. This means that they have the potential to tap into a wide range of markets and customers, allowing them to reach new heights of success. Investing in INMODE LTD is a great way to capitalize on the growing trend of non-surgical energy-based technologies. With their strong financial position, innovative product offerings, and potential for growth, INMODE LTD is an attractive option for investors looking for a reliable long-term investment.